XTRA:BASChemicals
BASF (XTRA:BAS) Launches SkinNexus Collag3n, Is The Recent Pullback Leaving Value On The Table?
BASF (XTRA:BAS) is back in focus after launching SkinNexus Collag3n, a 100% human-identical recombinant Collagen III fragment for the personal care market, developed with Bota Biosciences and premiered at in-cosmetics Global 2026.
See our latest analysis for BASF.
Despite the excitement around SkinNexus Collag3n and recent decisions to redeem outstanding notes early, BASF’s 30-day share price return is down 3.94% and the 90-day share price return is down 12.99%. At the same time, the 1-year...